Ozempic Lawsuits Explained: Current Legal Landscape and Key Claims These lawsuits primarily allege that Novo Nordisk and Eli Lilly failed to adequately warn patients and physicians about severe gastrointestinal complications, including gastroparesis (stomach paralysis), and emerging vision loss claims involving NAION
However, the findings of the SURMOUNT-1 clinical trial from 2022 saw significant weight loss when compared to placebo
Portanto, fundamental realizar um monitoramento regular e uma avaliao detalhada dos nveis de micronutrientes para garantir que a terapia seja eficaz na gesto do peso e, ao mesmo tempo, que previna deficincias nutricionais que possam comprometer a sade global do paciente
The Saxenda pen is easy to use, and the needle is very thin
You should remain on the lowest effective dose for as long as possible
Glutathione does not permanently alter melanin production